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http://dx.doi.org/10.1016/j.ccr.2012.10.024SUMMARYWe reported that Cullin4B-Ring E3 ligase complex (CRL4B) is physically associated with Polycomb-repres-
sive complex 2 (PRC2). We showed that CRL4B possesses an intrinsic transcription repressive activity by
promoting H2AK119 monoubiquitination. Ablation of Cul4b or depletion of CUL4B, the main component of
CRL4B, resulted in loss of not only H2AK119 monoubiquitination but also H3K27 trimethylation, leading to
derepression of target genes that are critically involved in cell growth and migration. We demonstrated
that CUL4B promotes cell proliferation, invasion, and tumorigenesis in vitro and in vivo and found that its
expression is markedly upregulated in various human cancers. Our data indicate that CUL4B promotes
tumorigenesis, supporting the pursuit of CUL4B as a target for cancer therapy.INTRODUCTION
Compared to other histone modifications, ubiquitination repre-
sents a very large modification and is mainly found on H2A lysine
119 (K119) and H2B (K120 in human and K123 in yeast) (Kouzar-
ides, 2007). Polycomb group proteins are a family of epigenetic
regulators responsible for the repression of an array of genes
that are critically implicated in development and cell fate speci-
fication (Schuettengruber et al., 2007). Two main Polycomb
group complexes exist in mammals: PRC1 and PRC2. PRC1
catalyzes histone H2A K119 monoubiquitylation (H2AK119ub1)
and compacts chromatin (Wang et al., 2004), while PRC2 cata-
lyzes trimethylation of histone H3 at K27 (H3K27me3) and also
contributes to chromatin compaction (Simon and Kingston,
2009). It is believed that PRC1 and PRC2 interplay and that
H2AK119ub1 and H3K27me3 are functionally coordinated in
transcriptional repression (Mu¨ller and Verrijzer, 2009). Although
this premise is still cited in the literature, its operational
status is equivocal as there are genes that are targeted by
PRC2 without PRC1, and vice versa (Tavares et al., 2012).
Clearly, there is still much to be learned about the molecularSignificance
Cullin 4B (CUL4B) is a scaffold protein of the Cullin4B-Ring
However, recent studies indicate that CUL4B could also be
also involved in the nucleus-based functions. In addition, alth
a central role in transcriptional repression by coordinating with
to be clarified.We demonstrated CRL4B is an alternative histon
CRL4B and PRC1 bind to PRC2 subunits in a mutually exclusiv
tional interplay between H2AK119ub1 and H3K27me3 in trans
Canmechanism underlying the coordination between H2AK119ub1
and H3K27me3.
Cullin 4-Ring E3 ligases (CRL4), assembled with CUL4, DDB1,
and ROC1 as the core components, participate in a broad variety
of physiologically and developmentally controlled processes
such as cell cycle progression, replication, and DNA damage
response (Jackson and Xiong, 2009). In mammals, there are
two Cullin 4 members, CUL4A and CUL4B. Loss-of-function
mutation in the X-linked CUL4B causes mental retardation, short
statue, absenceof speech, andother phenotypes in humans (Zou
et al., 2007). InCUL4B heterozygotes, the cells inwhichwild-type
(WT) CUL4B allele is inactivated are severely selected against,
underscoring the functional importance of CUL4B in cellular
proliferation (Zou et al., 2007). Accordingly, Cul4b knockout
mice are embryonically lethal (Jiang et al., 2012). It is interesting
that CUL4B, unlike CUL4A and other Cullins, carries a nuclear
localization signal (NLS) in its N terminus and is also localized in
the nucleus (Nakagawa and Xiong, 2011; Zou et al., 2009), sug-
gesting that CUL4B might be involved in the nucleus-based
functions. We addressed these issues using molecular, cellular,
and epigenetic approaches plus animal models.E3 ligase complex (CRL4B) that functions in proteolysis.
localized in the nucleus, suggesting that CUL4B might be
ough it was shown that H2AK119 monoubiquitination plays
H3K27 trimethylation, the underlying mechanisms remains
emodification enzyme responsible for H2AK119ub1 and that
e manner. These data provide amolecular basis for the func-
cription repression.
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Figure 1. CRL4B Interacts with PRC2
(A) Immunoaffinity purification of CUL4B-contain-
ing protein complexes. Cellular extracts from
HeLa cells stably expressing FLAG (control) or
FLAG-CUL4B were immunopurified with anti-
FLAG affinity columns and eluted with FLAG
peptide. The eluates were resolved by SDS-PAGE
and silver-stained. The protein bands were
retrieved and analyzed by mass spectrometry.
Detailed results from the mass spectrometric
analysis are provided as Table S1.
(B) Western blotting analysis of the purified frac-
tions using antibodies against the indicated
proteins.
(C) Association of CRL4B with PRC2 in HeLa,
HEK293, and KYSE410 cells. Whole cell lysates
were immunoprecipitated with the antibodies
against the indicated proteins. Immunocomplexes
were then immunoblotted using antibodies
against the indicated proteins. IgG served as the
negative control.
(D) Cofractionation of the CRL4B complex and
the PRC2 complex by fast protein liquid chroma-
tography. Nuclear extracts of HeLa cells were
fractionated on a DEAE sepharose column fol-
lowed by a Superose 6 gel filtration column. The
fractions were analyzed by western blotting.
Molecular weight standards are shown on top (in
kDa). The predicted molecular size of each main
component of the CRL4B-PRC2 complex is
summarized on the right.
(E) Molecular interaction between DDB1 and
PRC2 subunits. GST pull-down experiments with
bacterially expressed GST-DDB1 and the in-vitro-
transcribed/translated indicated proteins.
(F) IP assays using lysates from HeLa cells tran-
siently expressing DDB1 siRNA or RbAp48 siRNA
showing decreased co-IP of CUL4B with EZH2
and SUZ12. The protein expression in these
experiments was examined by western blotting
using antibodies against the indicated proteins.
See also Table S1.
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Cullin 4B-RING E3 Ligase Is Physically Associated with
PRC2 In Vivo
In an effort to better understand the mechanistic role of CUL4B,
we used affinity purification and mass spectrometry to identify
the proteins that are associated with CUL4B in vivo. In these782 Cancer Cell 22, 781–795, December 11, 2012 ª2012 Elsevier Inc.experiments, FLAG-tagged CUL4B
(FLAG-CUL4B) was stably expressed in
HeLa cells. Cellular extracts were pre-
pared and subjected to affinity purifica-
tion using an anti-FLAG affinity gel.
Mass spectrometric analysis indicates
that CUL4B copurified with DDB1,
GRWD1, COPS3, COPS4, and COPS5,
as reported previously (Groisman et al.,
2003; Higa et al., 2006). It is interesting
that we found that CUL4B also copurified
with EZH2, EED, and RbAp48, all of whichare the core components of the PRC2 complex (Figure 1A). In
addition, heat shock 70 kDa protein 8 (HSP71/73) and Fanconi
anemia complementation group M (FANCM) were also detected
in the immunocomplex. However, BMI and RING1B, the core
components of PRC1 (Cao et al., 2005), did not copurify with
CUL4B (Figure 1B, bottom two panels), suggesting that the
association of CUL4B with PRC2 is specific. The presence of
Cancer Cell
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further confirmed by western blotting analysis (Figure 1B). The
detailed results of the mass spectrometric analysis are provided
in Table S1 (available online).
To further validate the in vivo interaction between Cullin 4B-
RING E3 ligase (CRL4B) and PRC1/2, total proteins from HeLa
cells, HEK293 cells (a human embryonic kidney cell line), and
KYSE410 cells (a human esophageal squamous cell carcinoma
cell line) were extracted and coimmunoprecipitation (co-IP)
experiments were performed with antibodies detecting the
endogenous proteins. Immunoprecipitation (IP) with antibodies
against CUL4B or DDB1 followed by immunoblotting (IB) with
antibodies against EZH2, SUZ12, EED, or RbAp46/48 represent-
ing PRC2 or against RING1B or BMI representing PRC1 demon-
strated that only the PRC2 core components were efficiently
coimmunoprecipitated with CUL4B and DDB1 (Figure 1C, upper
panels). Reciprocally, IP with antibodies against EZH2 or SUZ12
followed by IB with antibodies against CRL4B subunits CUL4B,
DDB1, or ROC1 or against the two PRC1 core components in
these three cell lines revealed that both PRC1 and CRL4B
complexes were coimmunoprecipitated with PRC2 (Figure 1C,
middle panels). However, only PRC2 components could be cop-
urified with PRC1 (Figure 1C, lower panels). These results
suggest that CRL4B and PRC1 proteins bind with PRC2 compo-
nents in a mutually exclusive manner.
To further support the observation that CRL4B complex is
associated with PRC2 in vivo, protein fractionation experiments
were carried out with nuclear proteins by fast protein liquid
chromatography (FPLC). Nuclear extracts derived from HeLa
cells were fractionated by DEAE sepharose, followed by
superpose 6 gel filtration chromatography. Western blotting
revealed a major peak at about 669-1000 kDa for CUL4B,
DDB1, and ROC1, and also for PRC2 core components EZH2,
SUZ12, EED, and RbAp46/48 (Figure 1D). Significantly, the
chromatographic profiles of CUL4B, DDB1, and ROC1 were
largely overlapped with that of the components of PRC2, sup-
porting the argument that CRL4B complex is associated with
PRC2 in vivo.
In order to further strengthen the argument, we next investi-
gated the molecular basis for the interaction between the
CRL4B complex and PRC2. For this purpose, GST pull-down
assays were performed using GST-fused CUL4B or GST-fused
DDB1 and in-vitro-transcribed/translated EZH2, SUZ12, EED,
RbAp46, and RbAp48. These experiments revealed that,
although CUL4B interacts directly with DDB1, it did not interact
with the PRC2 components that we tested. However, it was
shown that DDB1 could interact directly with the two DWDmotif
(DDB1-binding WD40 protein)-containing molecules, RbAp46
and RbAp48 (Figure 1E), suggesting that DDB1 and RbAp46/
48 could act as the bridge molecules in physically linking the
CRL4B complex and PRC2. It is interesting that the EED compo-
nent of PRC2, which also contains aWD40motif but has noDWD
motif, did not show a direct interaction with DDB1, consistent
with a previous report (He et al., 2006). The in vitro GST pull-
down results were further substantiated by in vivo co-IP experi-
ments in which depletion of either DDB1 or RbAp46/48 could
disrupt the interaction between CUL4B and the PRC2 subunits,
EZH2 and SUZ12, in HeLa cells (Figure 1F). Taken together,
these results provide strong support for a physical associationCanbetween CRL4B and PRC2 that is bridged by DDB1 and
RbAp46/48.
CRL4B Exhibits Transcription Repressive Activity and
Promotes H2AK119 Monoubiquitination
The physical association between CRL4B and PRC2 prompted
us to investigate the hypothesis that CRL4B might be function-
ally involved in transcription repression. To this end, we fused
CUL4B to Gal4 DNA-binding domain (Gal4-CUL4B) and tested
the effect of this construct on the expression of a luciferase
reporter gene driven by TK (thymidine kinase) promoter plus
five copies of Gal4 binding sequence (Gal4-Luc) in HeLa cells
(Figure 2A, upper panel). The results revealed that the expression
of Gal4-CUL4B, but not FLAG-CUL4B, led to a drastic decrease
in the expression of the reporter gene (Figure 2A, lower panel),
indicating that CUL4B has an intrinsic transcriptional repression
activity and suggesting that CUL4B could act as a transcription
corepressor.
In order to further support this proposition, we investigated the
contribution of each of the different domains of CUL4B to its
transcriptional repressive function. A series of Gal4-DBD-fused
deletion constructs were generated, and the repressor activities
of those constructs were monitored using Gal4 UAS luciferase
reporter assays (Figure 2B, upper panel). Notably, deletion of
the NLS (1–137 amino acids [aa]) (DNLS) or NEDD8 neddylation
domain (824–895 aa) (DNEDD8) did not affect their repressive
activities, whereas deletion of either the DID (DDB1-interacting
domain) region (137–287 aa) (DDID) or Cullin domain (578–718
aa) (DCullin) or both resulted in a significant reduction of the
transcriptional repressive activity of CUL4B (Figure 2B, lower
panel). Thus, it appears that both DID and Cullin domains are
required for the transcriptional repressive activity of CUL4B,
suggesting that the interaction with DDB1 and ubiquitination
function of CUL4B are indispensable for its transcription repres-
sive function.
To further explore the functional connection between CUL4B
and PRC2, we performed loss-of-function experiments in the
Gal4 UAS luciferase reporter system. As shown in Figure 2C,
knockdown of DDB1, EZH2, or RbAps, the components of
PRC2, led to a significant reduction of the transcriptional repres-
sive activity of CUL4B, while depletion of BMI or RING1B, the
core components of PRC1, had little effect. Again, these exper-
iments suggested that CUL4B functions in transcriptional
repression in the context of CRL4B and supported our hypoth-
esis that CRL4B and PRC2 are functionally connected.
H2AK119 monoubiquitination was reported to play a central
role in transcriptional repression by coordinating with
H3K27me3 (Baarends et al., 2005; Mu¨ller and Verrijzer, 2009).
Based on our observations that CRL4B and PRC2 are physically
and functionally connected, we thus wanted to know whether
CRL4B exerts transcriptional repressive activity through
H2AK119 monoubiquitination. For this purpose, we performed
quantitative chromatin IP (qChIP) assay in HeLa cells that were
stably expressing Gal4-UAS reporter (HeLa-Gal4-Luc) to inves-
tigate the recruitment of DDB1 and EZH2 to and the changes
of H2AK119ub1, H3K27me3, and H3K4me3 on the Gal4
promoter after transfection of these cells with Gal4-CUL4B or
control Gal4-DBD. The results showed that artificial recruitment
of CUL4B resulted in the recruitment of DDB1 and EZH2,cer Cell 22, 781–795, December 11, 2012 ª2012 Elsevier Inc. 783
Figure 2. CUL4B Requires Its DID Domain and Cullin Domain for Optimal Repressive Activity
(A) CUL4B possesses an intrinsic transcription repressive activity. Gal4-CUL4B construct or a control vector (containing Gal4-DBD only) was transfected into
HeLa cells stably expressing Gal4-UAS reporter (HeLa-Gal4-Luc cells). Gal4 luciferase reporter activity was measured.
(B) Identification of the essential domains required for the transcriptional repressive activity of CUL4B. The upper panel shows the schematic of the CUL4B
deletions fused to the C terminus of GAL4 DNA-binding domain. The region fused toGal4-DBD is graphically depicted. In the lower panel, Gal4 luciferase reporter
assay was performed in HeLa-Gal4-Luc cells by transfection of Gal4-DBD-fusion deletion expression vectors. Relative activity is scored with , +, ++, or +++
corresponding to the significance to facilitate the interpretation of the data.
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level of H3K4me3 (Figure 2D, left panel); whereas RING1B,
a core component of the PRC1 complex, which was reported
to contribute to the monoubiquitination of hisone H2AK119
(deNapoles et al., 2004), was dispensable in this case (Figure 2D,
left panel). These experiments support an argument that CRL4B
is functionally associated with H2AK119 monoubiquitination.
Next, qChIP experiments were performed in HeLa-Gal4-Luc
cells that were transfected with Gal4-CUL4B, Gal4-DDID,
Gal4-DCullin, or control Gal4-DBD to investigate the recruitment
of DDB1 and EZH2 to and the changes of the H2AK119ub1 and
H3K27me3 on the Gal4 promoter. The results showed that,
compared to Gal4-CUL4B, DDID mutant lost the ability to recruit
endogenous DDB1 or EZH2 but still could bind to Gal4-UAS with
the artificial recruitment by Gal4-DBD tag and conduct H2AK119
monoubiquitination through classical E1/E2machinery, resulting
in a marginal decrease in monoubiquitination on H2AK119 (Fig-
ure 2D, right panel). Although DCullin mutant retained the ability
to recruit endogenous DDB1, it had no enzymatic activity on
H2AK119 (Figure 2D, right panel), thus losing the ability to recruit
EZH2 and trimethylate H3K27. These data are in agreement with
a functional scheme of CRL4B in which CUL4B relies on its Cullin
domain to recruit the enzymatic activity while it uses the DID
domain to capture the substrates, favoring our argument that
CRL4B promotes H2AK119 monoubiquitination.
To further validate this proposition, we performed in vitro
ubiquitination assays. HeLa cells were transfected with FLAG-
RING1B, FLAG-CUL4B, FLAG-DDID, FLAG-DCullin, or FLAG
control vector. Cell lysates were affinity purified using FLAG
M2 affinity gel, followed by in vitro ubiquitination assays. The
results showed that H2AK119 is monoubiquitinated by CRL4B
in an E1/E2- and E3-dependent manner (Figure 2E, left panel).
It is interesting that, while DDID could weakly monoubiquitinate
H2A on lysing 119, DCullin completely lost such enzymatic
activity (Figure 2E, left panel). Co-IP experiments further con-
firmed that the DID domain is responsible for the formation of
the CRL4B-PRC2 machinery, while Cullin domain is responsible
for the binding of the ring finger protein ROC1 along with E1/E2/
E3 (Figure 2E, right panel). As a positive control, affinity-purified
FLAG-RING1B elution was more efficient in the catalysis of
H2AK119ub1 than FLAG-CUL4B elution (Figure 2E, left panel).(C) Effect of depletion of DDB1, EZH2, BMI, or RING1B on CUL4B repressive activ
constructs along with the indicated shRNAs for 48 hr before luciferase assay. sh
(D) CUL4B confers repressive activity through H2AK119ub1 catalysis and PRC2
Gal4-DBD, Gal4-CUL4B, or its deletion constructs. Chromatin was immunoprec
H2AK119 monoubiquitination. DNA enrichment was analyzed at the Gal4 promot
the error bars represent mean ± SD of three independent experiments, and a tw
(E) The left panel shows in vitro ubiquitination analysis with recombinant CUL4
recombinant H2A (substrate) along with ubiquitin and ATP. Reactants were sub
shows the quality of the isolated complexes. Arrows correspond to the overexpres
FLAG-CUL4B or FLAG-tagged mutants, and whole-cell extracts were immunopre
against DDB1, ROC1, EZH2, SUZ12, RbAps, RING1B, or BMI.
(F) In vitro ubiquitination with recombinant His6-tagged H2A and its mutants (Mu
Coomassie blue and shown on the bottom. Exp, exposure.
(G) Upper panels show (left) Coomassie blue staining of CRL4B complex (con
ubiquitination analysis using recombinant His6-tagged CRL4B alone or with WD40
served as a negative control. In the lower panels, western blotting analysis show
(H) CUL4B is required for the binding of EZH2 to chromatin and shares the same tr
HeLa cells and analyzed by immunoblotting with the indicated antibodies. Histon
See also Figure S1.
CanExperiments with H2A and its mutants, K118/R, K119/R, and
K118/R+K119/R, indicated that the major ubiquitination site is
K119, while residual ubiquitination is found at K118, as reported
previously (Richly et al., 2010) (Figure 2F). It is known that Cullins
do not directly bind to their substrates directly; they rely on
adaptor/receptor proteins in their substrate recognition, such
as F-box proteins for CUL1, BTB proteins for CUL3, and WD40
proteins for CUL4 (Zimmerman et al., 2010). To determine which
WD40 protein is used for CUL4B to recognize H2AK119, we
purified CRL4B subunits CUL4B, DDB1, and ROC1, respec-
tively, from Sf9 insect cells. In vitro ubiquitination assays with
the purified proteins showed that the WD40 protein RbAp46/
48, not EED, acted as the substrate adaptor/receptor for
CUL4B to recognize H2AK119 (Figure 2G, upper panels). Con-
versely, knocking down RbAp48 resulted in the decrease of
H2AK119ub1 (Figure 2G, lower panels). Interestingly, we also
found that the amount of chromatin-bound EZH2 was positively
correlated with the expression level of CUL4B (Figure 2H) and
that the transcription factors such as JARID2 and PHF1 that
are essential for PRC2 recruitment (Sarma et al., 2008; Shen
et al., 2009) could also interact with CRL4B (Figure S1), further
supporting a functional connection between CRL4B and PRC2.
Depletion of CUL4B or Ablation of Cul4b Resulted
in the Loss of H2AK119ub1 as well as H3K27me3
To further explore the functional relationship between CUL4B
and PRC2, we next investigated whether CUL4B depletion
would alter H2AK119ub1 and H3K27me3 in vivo. CUL4B-
specific shRNA were tagged with enhanced green fluorescent
protein (EGFP) and transfected into HeLa cells. Forty-eight hours
posttransfection, cells were fixed and stained with antibodies
recognizing CUL4B, H2AK119ub1, and H3K27me3. As shown
in Figure 3A, although the expression of EZH2 was not affected
by CUL4B knockdown, the signals representing H2AK119ub1
and H3K27me3 were significantly reduced in CUL4B-depleted
cells, while H3K4me3 signals were slightly increased (marked
by arrows). These observations were corroborated by western
blotting (Figure 3B).
To further explore the importance of CUL4B in PRC2-
mediated gene silencing in vivo, we examined the effect of
CUL4B deficiency on the global level of H2AK119ub1 andity. HeLa-Gal4-Luc cells were transiently transfected with DBD or DBD-CUL4B
SCR, control scrambled shRNA.
recruitment. ChIP experiments were performed with transient transfection of
ipitated with antibodies against the proteins indicated at the bottom. ubH2A,
er and the results are presented as fold of enrichment over control. In (A–D), all
o-tailed t test was performed (*p < 0.05; **p < 0.01; ***p < 0.001).
B and CUL4B deletions incubated with different combinations of E1/E2 and
jected to IB with the indicated antibodies. A silver-stained gel on the bottom
sed FLAG-tagged proteins. In the right panel, HeLa cells were transfected with
cipitated with anti-FLAG M2 resin followed by western blotting with antibodies
t) purified from Sf9 insect cells. The recombinant substrates were stained by
taining CUL4B, DDB1, and ROC1) purified from Sf9 cells and (right) in vitro
proteins RbAp48 or EED as substrate adaptor/receptors. His6-tagged CUL4B
s decrease in H2AK119ub1 in HeLa cells upon RbAp48 knockdown.
anscription factors with PRC2. Chromatin-bound fractions were prepared from
e H3 served as a loading control.
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Figure 3. Knockdown of CUL4B or Ablation of Cul4b Resulted in Reduced H2AK119 Monoubiquitination and H3K27 Trimethylation
(A) HeLa cells were transiently transfected with EGFP-carrying CUL4B shRNA and stained with antibodies against CUL4B or EZH2 (red) or against H2AK119ub1,
H3K27me3, or H3K4me3 (red). Nucleus was counterstained by DAPI. Significant decrease in H2AK119ub1 and H3K27me3 levels was marked with arrows.
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usually die between 8.5 and 9.5 days postcoitum (dpc), we per-
formed immunostaining on paraffin-embedded Cul4b WT and
Cul4b null (KO) embryos at 7.5 dpc. Immunostaining revealed
a significant decrease in H2AK119ub1 and H3K27me3 in the
Cul4b null embryos, although the level of Ezh2 was comparable
to that in WT E7.5 embryos (Figure 3C). These results support
a notion that CUL4B is required for the monoubiquitination of
H2AK119 and trimethylation of H3K27 during early embryonic
development. In addition, examination of the global level of
H2AK119ub1 and H3K27me3 in liver from liver-specific Cul4b
knockout mice [Cul4b (loxp/Y)/Mx-1-Cre(+) and Cul4b (loxp/Y)/
Alb-Cre(+)] by western blotting showed a significant reduction
of both H2AK119ub1 and H3K27me3 in liver (Figure 3D), further
supporting the arguments that CUL4B is required for the trime-
thylation of H3K27 and that CUL4B and PRC2 are functionally
connected.
Genome-wide Identification of Transcription Targets
for the CRL4B/PRC2 Complex
To further investigate the functional connection between CRL4B
and PRC2 and to explore the biological significance of this
connection, we next analyzed the genome-wide transcriptional
targets of the CRL4B/PRC2 complex using the ChIP-on-chip
(ChIP-on-chip) approach. In these experiments, ChIP experi-
ments were conducted in KYSE410 cells with antibodies against
CUL4B, EZH2, or BMI. Following ChIP, CUL4B-, EZH2-, and
BMI-associated DNAs were amplified using nonbiased condi-
tions, labeled, and hybridized to an oligonucleotide array
covering 2.7 kb (2.2 kb to +0.5 kb with respect to transcription
start sites) of 18,028 annotated transcripts in the NCBI database
with a false discovery rate less than 0.05 (GEO accession
number: GSE41639). The data from CUL4B antibodies (1,463
genes) were then analyzed with the data from EZH2 (3,705
genes) and BMI antibodies (891 genes) for the identification of
common targets, or cotargets (Figure 4A, left panel). The detailed
results of the ChIP-on-chip experiments were summarized in
Tables S2–S8. A total of 619 unique promoters were found to
be cotargeted by CUL4B and EZH2, among which only 53
were overlapped with the 891 targets of BMI, indicating a
predominant cooperation between PRC2 and CRL4B, at least
in KYSE410 cells. The cotargets of CUL4B/CRL4B and EZH2/
PRC2 were then classified into various cellular signaling path-
ways using Molecule Annotation System software (http://www.
capitalbio.com/lifescience/informationsystems/2572.shtml), with
a p value cutoff of 103 (Figure 4A, right panel). These signaling
pathways include Wnt, MAPK, focal adhesion, IGF, and
apoptosis that are critically involved in cell growth, survival,
migration, and invasion. The genes in these pathways include,
among others, PTEN, SOCS1, AXIN2, SIAH1, RUXN1, FANCB,
MCM8, COL4A1, IGFBP3, and CDKN2A (p16), that are known
to be implicated in apoptosis and tumor suppression. Signifi-(B) Western blotting analysis showing decrease in H2AK119ub1 and H3K27me3 i
RING1B knockdown served as a positive control (lower panels).
(C) Immunohistochemical staining of 7.5 dpc in utero embryo sections using antibo
panels) and Cul4b KO (right panels) embryos. Different magnifications of the sam
(D) Western blotting analysis showing loss of H2AK119ub1 and H3K27me3 as w
H2A and H3 were used as loading controls.
Cancantly, FOXO3, E2F1, IGFBP3, p16, and TGFBI have been
shown to be transcriptionally repressed by PRC2 (Chen et al.,
2009; Tan et al., 2007; Wu et al., 2010). Quantitative ChIP anal-
ysis in KYSE410 cells using specific antibodies against CUL4B,
EZH2, RING1B, H2AK119ub1, and H3K27me3 on selected
genes, including PTEN, SOCS1, AXIN2, CXCR2, FOXO3,
SIAH1, E2F1, RUXN1, FANCB, MCM8, NKD2, COL4A1,
IGFBP3, p16,MLL3, CABLES2, RNH1, and TGFBI, which repre-
sent each of the classified pathways, showed a strong correla-
tion between CUL4B/H2AK119ub1 and EZH2/H3K27me3
enrichments, validating the ChIP-on-chip results (Figures 4B
and 4C). Quantitative real-time PCR (qPCR) further showed
that the transcription levels of most of the target genes signifi-
cantly increased in KYSE410 cells upon knockdown of CUL4B
or EZH2 (Figure S2).
We next investigated the effect of EZH2 depletion on the
recruitment of CUL4B on endogenous target loci and vice versa.
To this end, we established KYSE410 cells in which EZH2
expression was knocked down by its shRNA. In these cells,
EZH2 was greatly reduced or barely detectable at the promoters
of its target genes (Figure 4D, left panel). It is interesting that ChIP
experiments with antibodies against CUL4B showed that EZH2
depletion resulted in onlymarginal or no effect on the recruitment
of CUL4B on the target promoters (Figure 4D, right panel).
However, in CUL4B-depleted KYSE410 cells, the recruitment
of EZH2 to its target promoters was greatly reduced (Figure 4E),
although the expression of EZH2 was not affected by CUL4B
knockdown (see Figure 3B). In addition, consistent with our
earlier observations, the levels of both H2AK119ub1 and
H3K27me3 were markedly decreased at all the tested target
genes upon CUL4B knockdown (Figure 4F). Collectively, these
data suggest that CRL4B may function to promote the recruit-
ment and/or the stabilization of PRC2 onto target promoters,
supporting our aforementioned arguments that CUL4B and
PRC2 are functionally connected and that CUL4B is required
for the trimethylation of H3K27.
Regulation of p16 and PTEN by the CLR4B/PRC2
Complex
Among the common target genes identified earlier, p16 and
PTEN are well-established tumor suppressor genes (Lowe and
Sherr, 2003; Salmena et al., 2008). We thus further investigated
the transcriptional regulation of p16 and PTEN by CUL4B. As ex-
pected, CUL4B knockdown in KYSE410, HeLa, HEK293, MCF-7
(human breast adenocarcinoma cell line), and U2OS (human
osteosarcoma cell line) led to increased expression of p16 and
PTEN at both the transcriptional level (Figure 5A, left panel)
and the protein level (Figure 5A, right panel). Significantly, the
levels of p16 and PTENwere also elevated inCul4b null embryos
(Figure 5B).
We then investigated the regulation of p16 and PTEN by the
CLR4B/PRC2 complex. ChIP assays in KYSE410 cells withn HeLa, HEK293, and KYSE410 cells upon CUL4B knockdown (upper panels).
dies recognizing mouse Cul4b, Ezh2, H3K27me3, and H2AK119ub1 inWT (left
e embryos are presented.
ell as Cul4b protein in conditional liver-specific Cul4b ablation mice. Histones
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Figure 4. CUL4B/CRL4B and EZH2/PRC2 Co-Occupy
Target Genes
(A) The left panel is a Venn diagram showing a statistically
significant overlap between promoters bound by CUL4B, EZH2,
and BMI in KYSE410 cells. The numbers represent the number of
the promoters that were targeted by the indicated proteins. The
right panel shows clustering of the 619 overlapping target genes
of CUL4B and EZH2 into functional groups.
The detailed results of the ChIP-on-chip experiments are
provided in Tables S2–S8.
(B and C) Verification of the ChIP-on-chip results by qChIP
analysis of the indicated genes in KYSE410 cells.
(D–F) qChIP analysis of selected promoters in the KYSE410 cells
after transfection with control shRNA or shRNAs targeting
CUL4B or EZH2 using the indicated antibodies. Results are
represented as fold change over control. GAPDH served as
a negative control. Error bars represent mean ± SD of three
independent experiments. See also Figure S2 and Tables S2–S8.
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mmnuoglobulin G (IgG) revealed that CRL4B and PRC2 co-
occupied the promoters of p16 and PTEN (Figure 5C, upper788 Cancer Cell 22, 781–795, December 11, 2012 ª2012 Elsevier Inc.panels). To further test our proposition that CRL4B
and PRC2 function in the same protein complex
at p16 and PTEN promoters, sequential ChIP or
ChIP/Re-ChIP experiments (Wang et al., 2009)
were performed. In these experiments, soluble
chromatins were first immunoprecipitated with anti-
bodies against CUL4B, DDB1, EZH2, SUZ12, or
H2AK119ub1, while RING1B served as a negative
control (Figure 5C, upper panels). The immunopre-
cipitates were subsequently reimmunoprecipitated
with appropriate antibodies. The results showed
that, in precipitates, the p16 and PTEN promoters
that were immunoprecipitated with antibodies
against CUL4B could be reimmunoprecipitated with
antibodies against DDB1, EZH2, SUZ12, or
H2AK119ub1 (Figure 5C, lower panels). Similar
results were obtained when initial ChIP was done
with antibodies against DDB1, EZH2, SUZ12, or
H2AK119ub1. Furthermore, profiling of the binding
patterns of CUL4B, DDB1, EZH2, and SUZ12 by
qChIP on a region of 10 kb upstream and down-
stream of the transcription start sites of p16 or
PTEN loci revealed a perfect overlap of the occu-
pancy sites of these proteins, while RING1B/PRC1
binds mainly downstream from the transcription start
sites (TSS) of p16 locus, which is different from
CRL4B/PRC2 (Figure 5D). Taken together, these
results support the idea that CRL4B and PRC2
occupy the p16 and PTEN promoters in one multiunit
complex.
In order to determine a functional connection
between CRL4B and PRC2 on p16 and PTEN
promoters, KYSE410 cells were transfected with
shRNAs specifically against CUL4B, DDB1, EZH2,
or SUZ12. Each of these shRNA led to a significant
reduction in the expression of its target gene without
causing detectable changes of the nontargetedgenes (Figure 5E). qChIP analyses showed that knockdown of
the expression of CUL4B or DDB1 led to a significant reduction
of the binding of EZH2 and SUZ12 to the promoters of p16 and
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in only a marginal decrease in the association of CUL4B and
DDB1 with the promoters of p16 and PTEN (Figure 5F), which
was consistent with the results shown in Figures 4D and 4E.
Notably, knockdown of either CUL4B or DDB1 led to a severe
decrease in H3K27me3 at the promoters of p16 and PTEN,
whereas knockdown of either EZH2 or SUZ12 resulted in
a limited reduction in the levels of H2AK119ub1 at the promoters
of p16 and PTEN (Figure 5F), suggesting that CRL4B-catalyzed
H2AK119ub1 acts sequentially and coordinately with PRC2-
mediated H3K27me3.
CUL4B Promotes Cell Proliferation and Invasion
Based on the role of PRC2 in cancer development and progres-
sion (Simon and Lange, 2008) and our observation that CRL4B
and PRC2 are physically and functionally associated, we next
investigated what role, if any, CUL4B plays in tumorigenesis.
For this purpose, we first analyzed the effect of gain-of-function
and loss-of-function of CUL4B and EZH2 on the cell cycle profile
of KYSE410 cells by propidium iodide staining and flow cytom-
etry. KYSE410 cells with stable CUL4B/EZH2 expression or
with CUL4B/EZH2 knockdown were synchronized at the G0/G1
phases by serum starvation for 24 hr, followed by being released
using normal growth media for another 12 hr. Compared with
control, CUL4B or EZH2 overexpression was associated with
a decreased cell population in G1 and an increased cell popula-
tion in the S phases, while KYSE410 cells exposed to CUL4B or
EZH2 shRNA exhibited an increase in the proportion of cells in G1
and a decrease in the proportion of cells in the S phases (Fig-
ure 6Aa). Growth curve assays showed that the S-phase accu-
mulation by CUL4B overexpression was not due to S phase
arrest (Figure 6Ab). The representative cytometric results from
these experiments are shown in Figure S3. Furthermore, western
blotting analysis showed that the expression level of CUL4B re-
mained constant at different cell cycle stages, excluding the
possibility that proliferation itself increases CUL4B expression
(Figure 6B). The cyclin D1 level was low in quiescent cells, and
it increased as cells progressed into G1, which served as
a control protein (Koepp et al., 1999). These data indicate that
CUL4B and EZH2 have similar effect on cell cycle progression
in KYSE410 cells, consistent with the role of p16 and PTEN in
arresting cells in the G1 phase (Weng et al., 1999; Zhang et al.,
1999). Moreover, colony formation assays further showed that
CUL4B overexpression was associated with a marked increase
in colony numbers, whereas CUL4B knockdown is associated
with a significant decrease in colony numbers (Figure 6C). In
addition, while overexpression of WT CUL4B resulted in 1.72-
fold increase in colony number, overexpression of CUL4BDCullin
had a dominant negative effect on colony formation (Figure 6D,
bars 1–3). Moreover, in agreement with the functional link
between CUL4B and p16 described earlier, the positive effect
of CUL4B overexpression on colony formation could be partially
offset by introduction of exogenous p16 and the decrease in
colony formation by CUL4B knockdown could be partially
rescued by treatment of cells with p16 shRNA (Figure 6D). In
addition, overexpression of CUL4B but knockdown of the
expression of EZH2 resulted in a diminished effect of CUL4B
on colony formation (Figure 6D, bars 6 and 7). Together, these
experiments support a notion that CUL4B promotes esophagusCancarcinoma cell proliferation and it does so, at least in part,
through cooperation with EZH2 and via repression of tumor
suppressor p16.
As stated earlier, PRC2 has also been implicated in epithelial-
to-mesenchymal transitions (EMT; Herranz et al., 2008). Thus,
we next investigated whether CUL4B has a role in EMT and
tumor metastasis. For this purpose, CUL4B was overexpressed
in KYSE410 cells via stable transfection, and the impact of the
gain-of-function of CUL4B on the invasive potential of these cells
was assessed using transwell invasion assay. The results
showed that, while overexpression of WT CUL4B resulted in
more than 3-fold increase in cell invasion, overexpression of
the Cullin domain-deleted CUL4B mutant had little effect (Fig-
ure 6E, bars 1–3). In addition, the increased invasiveness upon
CUL4B overexpression was probably achieved through
a concerted action by CRL4B and PRC2, as the effect of
CUL4B overexpression was diminished when EZH2 was
concomitantly knocked down (Figure 6E, bars 4 and 5). More-
over, the increase in invasiveness associated with CUL4B over-
expression could be blocked by PTEN overexpression (Fig-
ure 6E, bars 6 and 7). Collectively, these results indicate that
CUL4B promotes the invasive potential of KYSE410 cells,
possibly by acting in conjunction with PRC2 and by repressing
the expression of PTEN.
We next investigated the role of CUL4B in tumor development
and progression in vivo by implanting KYSE410 and EC9706
cells that had been engineered to stably express CUL4B shRNA
or control scrambled shRNA (shSCR) onto the subcutaneous
sites of athymic BALB/c mice. Growth of the implanted tumors
was monitored by measuring the tumor sizes every 4 days
over a period of 4 weeks. The results showed that tumor growth
was greatly suppressed by CUL4B knockdown, indicating that
CUL4B had a significant effect on promoting the tumor growth
(Figure 6F). Western blotting analysis confirmed the decrease
in the levels of H2AK119ub1/H3K27me3 and the increases in
the levels of p16 and PTEN proteins in the tumors with CUL4B
knockdown (Figure 6G). Immunohistochemical staining for Ki-
67, a well-documented marker for cellular proliferation, on serial
xenograft tumor sections showed that, compared to the control,
tumors with CUL4B knockdown exhibited significantly fewer Ki-
67-positive nuclei (Figure 6H). Taken together, these experi-
ments indicate that CUL4B promotes esophageal carcinoma
cell proliferation, invasion, and tumorigenesis in vitro and in vivo.
The Expression of CUL4B Is Upregulated in Esophageal
Carcinomas andPositively Correlatedwith TumorGrade
To further define the role of CUL4B in tumorigenesis, we
collected 182 esophageal carcinoma samples, 45 of them with
paired adjacent normal tissues, from esophageal cancer
patients and performed tissue microarrays by immunohisto-
chemical staining. CUL4B was found to be significantly upregu-
lated in tumors and its expression appeared to be positively
correlated with histological grades (Figures 7A and 7B). In 12
of 14 selected paired samples of grade II cancers, the level of
CUL4B mRNA was found to be higher in tumor tissue than in
adjacent tissue, as measured by qPCR (Figure 7C, upper panel)
and western blotting (Figure 7C, lower panel), and the levels of
p16 and PTEN generally showed an inverse trend with that of
CUL4B. Indeed, statistical analysis revealed a significantcer Cell 22, 781–795, December 11, 2012 ª2012 Elsevier Inc. 789
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Figure 5. Tumor Suppressor Genes p16 and PTEN Are Cotargeted by CLR4B and PRC2
(A) Clones in which CUL4B was stably knocked down were compared with the parental cell line with respect to the levels of mRNA (left panel) and protein (left
panel) of p16 and PTEN in HeLa, HEK293, KYSE410,MCF-7, and U2OS cells. ThemRNA levels were normalized to those of GADPH (left panel) and b-actin served
as a loading control for the western blotting (right panel).
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and PTEN were plotted against that of CUL4B in 30 paired
samples of grade II (Figure 7D). These data are consistent with
a role of CUL4B in promoting carcinogenesis and support the
observation that p16 and PTEN are downstream targets of
CUL4B.
To investigate whether the tumorigenic effect of CUL4B
could be extended to a broader scope of cancers, we
collected a series of carcinoma samples from esophageal,
lung, gastric, colon, pancreatic, cervical, renal, and bladder
cancer patients, with each type of carcinomas having at least
three samples paired with adjacent normal tissues. Tissue mi-
croarray analysis by immunohistochemical staining showed
a statistically significant upregulation of CUL4B expression in
carcinomas from multiple tissues compared to the adjacent
normal tissues, except for the carcinomas of urinary system
(Figure 7E). Since EZH2 has also been reported to be overex-
pressed in various cancers (Simon and Lange, 2008), we also
determined the expression profile of CUL4B and EZH2 using
the human cancer survey qPCR gene expression panel (Ori-
gene) in tumors originated from breast, colon, kidney, lung,
ovary, and thyroid (Figure 7F). The results showed that both
CUL4B and EZH2 are overexpressed in all of these cancer
groups compared with normal tissue controls except in the
kidney. Moreover, the cancer survey cDNA array data also re-
vealed a significant positive correlation between the expression
of CUL4B or EZH2 and tumor grade, especially in breast and
lung. The expression profiles of CUL4B and EZH2 were very
similar. Taken together, these data support a role for CUL4B
in promoting tumorigenesis and suggest that CUL4B could
serve as a biomarker for cancer diagnosis and a potential
target for cancer therapy.
DISCUSSION
Our data indicate CUL4B is a transcriptional corepressor that
regulates transcription by recruiting PRC2. The CRL4B subunits
do not contain chromatin-binding domains which could con-
tribute to PRC2 recruitment (Figure 7Ga). Although RbAp46/48,
two histone binding proteins, were identified to be the bridge
molecules for interaction between CRL4B and PRC2, it is more
probably that the role of RbAp46/48 in this CRL4B-PRC2
interaction is to recognize and bind histone H2A and H3 (Yoon
et al., 2003), thus to further stabilize the binding of this
multiunit complex to chromatin rather than to recruit PRC2. To
date, PRC2 has been shown to mediate transcription repression
by distinct sequence-specific transcription factors. Interestingly,
we found that JARID2 and PHF1 could also physically interact(B) Different magnifications of immunohistochemical staining using antibodies rec
7.5 dpc embryos.
(C) The CRL4B and PRC2 complexes exist in the same protein complex on the
KYSE410 cells with the indicated antibodies.
(D) ChIP analysis of the recruitment of CUL4B, DDB1, EZH2, SUZ12, and RING1
negative control. ChIP enrichments are presented as percentage of bound/input
denoted as black boxes. TSS (dashed line) are also presented in the figure.
(E) The knockdown efficiencies of CUL4B, DDB1, EZH2, and SUZ12 were confir
(F) qChIP analysis of the recruitment of the indicated proteins on p16 and PTEN
targeting CUL4B, DDB1, EZH2, or SUZ12. RING1B ChIP was also performed on t
control. Error bars represent mean ± SD of three independent experiments. *p <
Canwith CRL4B in HeLa cells, suggesting that CRL4B and PRC2
may share similar transcription factors thus respond to same
signal pathways. Of note, while DNA binding proteins are
believed to be responsible for PRC2 recruitment in mammals,
recent studies indicated that long noncoding RNA, such as
XIST, KCNQ1OT1, and HOTAIR, could also be involved in this
process (Maenner et al., 2010; Pandey et al., 2008; Tsai et al.,
2010). It is intriguing that Pcu4 and Rik1, the fission yeast
homologs of the CUL4 and DDB1, were reported to be involved
in noncoding RNA transcription (Hong et al., 2005; Li et al., 2008)
(Figure 7Gb). Clearly, future investigations are needed to explore
the scope and the variety of the functionality of the CRL4B/PRC2
complex and to determine whether this functionality involves
additional elements.
Recent studies showed that there are genes targeted by PRC2
without PRC1, and vice versa (Ku et al., 2008; Tavares et al.,
2012). Our findings suggest that CRL4Bmay function as an alter-
nate histone modification enzyme responsible for H2AK119ub1,
providing a molecular basis for the interplay of H2AK119ub1 and
H3K27me3 in chromatin remodeling. The replacement of PRC1
by CRL4B could also explain why PRC1 and PRC2 are un-
coupled in some instances.
The regulation of p16 and PTEN by CRL4B/PRC2 may have
significant physiological implications. In addition to the proposi-
tions that CRL4 possibly promotes tumorigenesis through
degradation of p53 as well as several cyclin-dependent kinase
inhibitors (Banks et al., 2006; Nishitani et al., 2008), our findings
add another element to the understanding of the oncogenic
potential of CRL4. In this regard, it is interesting to note that
CUL4A-DDB1 is reported to cooperate with the MLL1 complex
in mediating oncogene-induced p16 activation (Kotake et al.,
2009). It appears that CUL4A and CUL4B may have opposite
effects on p16 expression and function in a competitive manner.
The derepressive effect of CUL4B’s loss-of-function combined
with the activating effect of CUL4A’s gain-of-function resulted
in further p16 activation in HeLa and HEK293 cells, in which
p16 is highly expressed due to the inactivation of Rb pathway
(Kotake et al., 2007). Future studies would clarify whether
CRL4 complexes could exert opposite activities depending on
the different Cullin member in the complex.
In summary, our study revealed that CRL4B regulates tran-
scription by monoubiquitinating H2AK119 and by coordinating/
facilitating PRC2-catalyzed H3K27me3, thus providing a molec-
ular basis for the interplay between histone ubiquitination and
methylation in chromatin remodeling. Our data indicate that
CUL4B functions as a transcription corepressor and a potential
oncogene, supporting the pursuit of CUL4B as a target for
cancer therapy.ognizing mouse p16 and PTEN in WT (left panels) and Cul4B KO (right panels)
p16 and PTEN promoters. ChIP and Re-ChIP experiments were performed in
B on PTEN and p16 gene loci in KYSE410 cells. Rabbit normal IgG served as
signal. The position of the qPCR amplicons (arrows) relative to the genes are
med by qPCR (left panel) or western blotting (right panel).
promoters in KYSE410 cells after transfection with control shRNA or shRNAs
he binding peak shown in Figure 5D. Purified rabbit IgG was used as a negative
0.05 and **p < 0.01 (two-tailed unpaired t test).
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Figure 6. CUL4B Promotes Esophageal Carcinogenesis In Vitro and In Vivo
(A) CUL4B promotes cellular proliferation. KYSE410 cells stably expressing CUL4B/EZH2 or stably transfected with CUL4B/EZH2 shRNA were subjected to cell
cycle analysis by flow cytometry (a) and growth curve assay (b). Error bars represent mean ± SD of three independent experiments.
(B) CUL4B remained unchanged throughout the cell cycle in KYSE410 cells. The cells were synchronized at the G0/G1 phases by serum starvation for 24 hr,
followed by releasing into normal growth media. Propidium iodide FACS analysis is presented at the top of the panel.
(C) CUL4B enhances the colony-forming efficiency of esophageal cancer cells. KYSE410 cells and EC9706 cells stably expressing corresponding plasmids or
shRNA vectors were maintained in culture media for 14 days under the presence of 1 mg/ml G418 prior to being stained with crystal violet.
(D) Enhancement in colony-forming efficiency by CUL4B is p16 and EZH2-dependent. KYSE410 cells were transiently transfected with empty vector, CUL4B
expression vector, CUL4DCullin expression vector, p16 expression vector, control shRNA, EZH2 shRNA, CUL4B shRNA and p16 shRNA as indicated and
maintained in culture media for 14 days under the presence of 1 mg/ml G418 and stained with crystal violet. The protein expression in these experiments was
examined by western blotting using antibodies against the indicated proteins.
(E) CUL4B enhances the invasiveness of esophageal cancer cells. KYSE410 cell were transiently transfected with empty vector, CUL4B expression vector,
CUL4DCullin expression vector, PTEN expression vector, control shRNA, or EZH2 shRNA as indicated and maintained in culture media for 14 days under the
presence of 1 mg/ml G418 and assayed for transwell assay. In each experiment in (C–E), at least six randomly selected view fields (403 magnifications) were
scored. The number of colonies or transwelled cells in each condition was counted and expressed as mean ± SD from triplicate experiments.
(F) CUL4B promotes esophageal tumorigenesis. KYSE410 and EC9706 cells stably expressing CUL4B shRNA or shRNA were transplanted into athymic mice.
Tumorsweremeasured every 4 days using a vernier calliper, and the volumewas calculated according to the formula: 1/63 length3width2. The growth curves of
tumors (a), representative images of tumor-bearingmice (b), and their tumors and the average tumormass of each group (c) are shown. Each point represents the
mean ± SEM. *p < 0.05 and **p < 0.01 (two-tailed unpaired t test).
(G) Western blotting analysis showing loss of H2AK119ub1 and H3K27me3 as well as increase in p16 and PTEN proteins in the tumors.
(H) CUL4B promotes esophageal tumorigenesis through accelerating cell proliferation. Immunohistochemical staining was used, using antibodies against mouse
CUL4B and Ki-67 on xenograft tumor sections.
See also Figure S3.
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Figure 7. CUL4B Is a Potential Cancer Biomarker
(A) Immunohistochemical staining of CUL4B in normal esophageal tissue and esophageal carcinomas (histological grades I, II, and III). (B) The positively stained
nuclei (in percentages) in grouped samples were analyzed by two-tailed unpaired t test (*p < 0.05; **p < 0.01; ***p < 0.001).
(C) The expression of CUL4BmRNA and protein is upregulated in esophageal carcinomas. Total RNAs and proteins in paired samples of esophageal carcinomas
versus adjacent normal esophageal tissues were extracted, and the expression of CUL4B was measured by qPCR and western blotting. mRNA levels were
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Tumor Xenografts
KYSE410 and EC9706 esophageal cancer cells stably transfectedwith CUL4B
shRNA or scrambled control shRNA were collected, and 23 106 viable cells in
100 ml PBS were injected subcutaneously into 6- to 8-week-old BALB/c nude
mice (Vital River Laboratories, Beijing, China). Eight animals per group (male =
4 and female = 4) were used in each experiment. Tumors were measured every
4 days using a vernier caliper, and the volume was calculated according to the
formula: 1/63 length3 square width. All studies were approved by the Animal
Care Committee of Shandong University Medical School.
Tissue Specimen and Immunohistochemistry
Esophageal carcinoma tissues were obtained from Qilu Hospital of Shandong
University. Samples were frozen in liquid nitrogen immediately after surgical
removal and maintained at 80C until analyzed. Samples were fixed in 4%
paraformaldehyde (Sigma-Aldrich) at 4C overnight, and then embedded in
paraffin, sectioned at 8 mm onto Superfrost-Plus Slides, and processed per
standard protocols using DAB staining. All human tissue was collected using
protocols approved by the Ethics Committee of Shandong University Medical
School, and informed consent was obtained from all patients.
ACCESSION NUMBERS
ChIP-on-chip information was deposited at the Gene Expression Omnibus
database (http://www.ncbi.nlm.nih.gov/geo/) with the accession number
GSE41639.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, eight tables, and Supple-
mental Experimental Procedures and can be found in this article online at
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